Skip to main content

Alcon Inc(ALC-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low75.26
Day High75.94
Open:75.50
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Zacks Investment Research
ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth
ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Mizuho Securities Gives a Buy Rating to Alcon (ALC)
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Alcon (ALC) and Elanco Animal Health (ELAN)
Business Wire
Systane Steps Up to the Plate as the Official Eye Drop of the Toronto Blue Jays, Raising Awareness of Dry Eye in Canada
Tipranks
Alcon Sets April 30, 2026 AGM, Proposes New Director and CHF 0.28 Dividend
Tipranks
Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and HCA Healthcare (HCA)
Tipranks
Analysts Offer Insights on Healthcare Companies: Rubicon Organics (OtherROMJF), Alcon (ALC) and Milestone Pharmaceuticals (MIST)
Motley Fool
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition
Tipranks
Transformational Opportunities: UBS Suggests 2 Longevity Stocks to Buy as the $8T Aging Boom Accelerates
Tipranks
UBS Remains a Buy on Alcon (ALC)
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Rapport Therapeutics, Inc. (RAPP), Jazz Pharmaceuticals (JAZZ)
Tipranks
Goldman Sachs Sees Market Warning Signs – But Likes These 2 Stocks
Tipranks
Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and Tyra Bioscience (TYRA)
Tipranks
Analysts’ Top Healthcare Picks: Scholar Rock Holding (SRRK), Alcon (ALC)
Tipranks
Alcon Earnings Call: Growth, Tariffs and Margin Plans
Tipranks
Rothschild & Co Redburn Keeps Their Buy Rating on Alcon (ALC)
Tipranks
Alcon (ALC) Gets a Sell from Bank of America Securities
Tipranks
Alcon (ALC) Receives a Hold from Barclays
Tipranks
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN), Mirum Pharmaceuticals (MIRM) and Alcon (ALC)
Tipranks
Analysts Conflicted on These Healthcare Names: Teladoc (TDOC) and Alcon (ALC)
Tipranks
Alcon (ALC) Receives a Sell from Bank of America Securities
Tipranks
Alcon’s 2025 Annual Report Showcases Innovation-Led Growth and Strategic Eye-Care Expansion
Tipranks
Alcon Posts Strong Q4 2025 Sales Growth and Robust Cash Generation
Motley Fool
Alcon (ALC) Q4 2025 Earnings Call Transcript
Zacks Investment Research
Alcon's Q4 Earnings Miss Estimates, Stock Falls, Revenues Rise Y/Y
Alcon's Q4 Earnings Miss Estimates, Stock Falls, Revenues Rise Y/Y
Motley Fool
Bridger Dumps 301,000 Bath & Body Works Shares Worth $7.7 Million
Tipranks
BTIG Sticks to Their Buy Rating for Alcon (ALC)
Tipranks
Alcon (ALC) Receives a Buy from RBC Capital
Tipranks
RBC Capital Sticks to Its Buy Rating for Alcon (ALC)
Tipranks
RBC Capital Remains a Buy on Alcon (ALC)
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Mirum Pharmaceuticals (MIRM), REPRO-MED Systems (KRMD) and Alcon (ALC)

Profile

Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.